July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 17, 2025

Medical Oddities: Plague, Still a Thing

Old threats, odd urges, crispy skin, toxic air, and tea with benefits—all in one go.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 14, 2025

Premenstrual Disorders Linked With Increased Risk of Cardiovascular Diseases 

A large Swedish study found that women diagnosed with premenstrual disorders had a modest but consistent increase in the risk of several types of cardiovascular diseases, including stroke, hypertension, and arrhythmia.

Conexiant

July 11, 2025

Small Air Pollution Increases Linked to Fibrosis

A large imaging study found that even small increases in long-term exposure to fine particulate air pollution were linked to higher levels of myocardial fibrosis, a known marker of adverse heart remodeling, in both healthy individuals and patients with dilated cardiomyopathy.

Conexiant

July 09, 2025

Medical Oddities: Mondays May Mess With Hormones

Monday cortisol, THC slip-ups, rewiring retinas, tea-buffed muscles, and psyche gyms are what’s the buzz this week!

Conexiant

July 09, 2025

Once-Weekly Combo Injection Cuts Weight by 20% 

A large 68-week clinical trial found that a once-weekly combination injection of cagrilintide and semaglutide led to significant and sustained weight loss in adults with overweight or obesity, with over half achieving at least 20% weight reduction.

Conexiant

July 09, 2025

ESC: Vaccines May Prevent Major Heart Events

A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.

Conexiant

July 09, 2025

Evening Dosing Lowers BP Better, Study Finds

Researchers found that bedtime dosing of olmesartan-amlodipine improved nocturnal blood pressure control without increasing adverse events in patients with hypertension.

Conexiant